Traders should monitor for immediate downward pressure on HURA stock price due to the ATM offering, especially given the recent earnings release. The dilution of $1.25 per share represents a significant immediate loss for new investors. Consider that management may be taking advantage of a temporary price spike following the Kineta merger and Phase 3 trial initiation to raise capital.
Price Chart
Executive Summary
TuHURA Biosciences is conducting an at-the-market (ATM) offering of up to $50 million in common stock, following a recent $12.6 million private placement. The company reported its 2025 financial results just one week prior, indicating a need for capital. The offering will dilute new investors by $1.25 per share and is being used for general corporate purposes.
Key Facts
- ATM offering of up to $50 million in common stock priced at market rates
- Last reported stock price was $1.79 per share on March 31, 2026
- Recent $12.6 million private placement completed in June 2025
- Company reported 2025 financial results on April 1, 2026, just one week before this filing
- New investors will experience $1.25 per share dilution based on $1.79 offering price
- Proceeds to be used for working capital and general corporate purposes
Financial Impact
Up to $50 million in equity dilution with 3% underwriting commission
Risk Factors
- Significant immediate dilution for new investors ($1.25 per share)
- ATM offering structure allows company to sell shares opportunistically at market highs
- Proceeds are for general corporate purposes with no specific allocation
- Recent capital raise ($12.6M private placement) suggests ongoing funding needs
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001193125-26-147748 |
| Document: 0001193125-26-147748-index-headers.html | 0001193125-26-147748 |
| Document: 0001193125-26-147748-index.html | 0001193125-26-147748 |
| Document: 0001193125-26-147748.txt | 0001193125-26-147748 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 8-K | $1.78 | awaiting T+60 | — | $2.11 (+18.54%) |
Sep 24, 2026 4w ago | 8-K | $2.10 | awaiting T+60 | — | $2.11 (+0.48%) |
Sep 17, 2026 5w ago | 8-K | $2.10 | awaiting T+60 | — | $2.11 (+0.48%) |
Sep 16, 2026 5w ago | 8-K | $2.09 | awaiting T+60 | — | $2.11 (+0.96%) |
Sep 4, 2026 7w ago | 8-K | $2.12 | awaiting T+60 | — | $2.11 (−0.47%) |
Aug 19, 2026 9w ago | 8-K | $2.22 | awaiting T+60 | — | $2.11 (−4.95%) |
Aug 14, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.11 (−14.57%) |
Aug 14, 2026 10w ago | Press Release | $2.47 | awaiting T+60 | — | $2.11 (−14.57%) |
Aug 13, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.11 (−14.57%) |
Jul 29, 2026 12w ago | 8-K | $2.17 $2.18 | ▲ +0.46% | ▼ −2.00% | $2.11 (−2.76%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers